September 27, 2022
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jane Park
Re: VectivBio Holding AG
Acceleration Request for Registration Statement on Form F-3
File No. 333-265546
Ladies and Gentlemen:
The undersigned registrant hereby respectfully advises the staff (the “Staff”) of the U.S. Securities and Exchange Commission that it is withdrawing its previous request that the above-referenced Registration Statement be declared effective on Monday, September 26, 2022. The registrant hereby undertakes to advise the Staff regarding any future acceleration request as soon as possible.
[Signature page follows]
Very truly yours,
VectivBio Holding AG
By: /s/ Claudia D’ Augusta
Claudia D’Augusta
Chief Financial Officer
cc: Scott Applebaum, VectivBio Holding AG
Brandon Fenn, Cooley LLP
Dayne Brown, Cooley LLP
Andreas Müller, Homburger AG